Development of Reagents for Application of At-211 to Targeted Radionuclide Therapy of Cancer

doi 10.2172/1032019
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Office of Scientific and Technical Information (OSTI)

Related search

Targeted Radionuclide Therapy With Astatine-211: Oxidative Dehalogenation of Astatobenzoate Conjugates

Scientific Reports
Multidisciplinary
2017English

Terbium-161 for PSMA-targeted Radionuclide Therapy of Prostate Cancer

European Journal of Nuclear Medicine and Molecular Imaging
MedicineNuclear MedicineRadiologyImaging
2019English

Introduction to Radiobiology of Targeted Radionuclide Therapy

Frontiers in Medicine
Medicine
2015English

Targeted Radionuclide Therapy

Journal of Labelled Compounds and Radiopharmaceuticals
Organic ChemistryNuclear MedicineRadiologyBiochemistryAnalytical ChemistryImagingSpectroscopyDrug Discovery
2007English

Global Trends Survey for Targeted Radionuclide Therapy

Nippon Hoshasen Gijutsu Gakkai zasshi
Medicine
2018English

Pretargeting of Astatine-211 for Therapy of Metastic Prostate Cancer

1999English

Preclinical Development of Targeted Stereotactic Body Radiation Therapy for Pancreatic Cancer

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2017English

Nuclear Model Calculations on the Production of Auger Emitter 165Er for Targeted Radionuclide Therapy

Journal of Modern Physics
2010English

Development of EGFR-Targeted Nanoemulsion for Imaging and Novel Platinum Therapy of Ovarian Cancer

Pharmaceutical Research
Organic ChemistryBiotechnologyMolecular MedicinePharmacologyPharmaceutical Science
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy